ATE406451T1 - Verankerte expression heterologer proteine - Google Patents

Verankerte expression heterologer proteine

Info

Publication number
ATE406451T1
ATE406451T1 AT96915775T AT96915775T ATE406451T1 AT E406451 T1 ATE406451 T1 AT E406451T1 AT 96915775 T AT96915775 T AT 96915775T AT 96915775 T AT96915775 T AT 96915775T AT E406451 T1 ATE406451 T1 AT E406451T1
Authority
AT
Austria
Prior art keywords
protein
heterologous
proteins
host cell
carrier protein
Prior art date
Application number
AT96915775T
Other languages
English (en)
Inventor
Gregory Maine
Linda Chovan
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE406451T1 publication Critical patent/ATE406451T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT96915775T 1995-05-15 1996-05-14 Verankerte expression heterologer proteine ATE406451T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44114195A 1995-05-15 1995-05-15

Publications (1)

Publication Number Publication Date
ATE406451T1 true ATE406451T1 (de) 2008-09-15

Family

ID=23751710

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96915775T ATE406451T1 (de) 1995-05-15 1996-05-14 Verankerte expression heterologer proteine

Country Status (7)

Country Link
EP (1) EP0826060B1 (de)
JP (1) JP4108122B2 (de)
AT (1) ATE406451T1 (de)
CA (1) CA2221192C (de)
DE (1) DE69637659D1 (de)
ES (1) ES2313727T3 (de)
WO (1) WO1996036722A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1290804B1 (it) * 1996-08-16 1998-12-11 Abbott Lab Saggio western blot perfezionato per l'individuazione di anticorpi specifici contro il virus hcmv

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124255A (en) * 1988-03-11 1992-06-23 Abbott Laboratories CKS method of protein synthesis
DE3828666A1 (de) * 1988-08-24 1990-03-01 Behringwerke Ag Expression funktionsfaehiger homologer und heterologer proteine auf der aeusseren membran von e.coli und anderen gramnegativen bakterien
US5646016A (en) * 1991-02-06 1997-07-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules
US5270181A (en) * 1991-02-06 1993-12-14 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
IT1266740B1 (it) * 1994-07-01 1997-01-14 Maria Paola Landini Materiale proteico ricombinante legante anticorpi contro il citomegalovirus umano, reagenti diagnostici derivati da tale

Also Published As

Publication number Publication date
JP4108122B2 (ja) 2008-06-25
WO1996036722A3 (en) 1996-12-19
EP0826060A2 (de) 1998-03-04
CA2221192A1 (en) 1996-11-21
DE69637659D1 (de) 2008-10-09
JPH11505123A (ja) 1999-05-18
ES2313727T3 (es) 2009-03-01
EP0826060B1 (de) 2008-08-27
CA2221192C (en) 2011-11-01
WO1996036722A2 (en) 1996-11-21

Similar Documents

Publication Publication Date Title
EP1806402A3 (de) CTLA4/CD28 Liganden und deren Anwendungen
BRPI9811940A (pt) vetor de expressão para um polipeptídeo de ligação da interleucina-18 (il-18-bp), célula hospedeira procariótica transformada com o referido vetor, processo para produção de il-18-bp, proteína de fusão compreendendo o referido polipeptídeo, bem como il-18bp modificada.
EP0799317B8 (de) Verfahren zur sekretion thrombopoitin polypeptide
HUP0001650A2 (hu) Javított expressziós vektorok
WO1999063088A3 (en) Membrane-bound proteins and nucleic acids encoding the same
WO1999061469A3 (en) Prostate growth-associated membrane proteins
MXPA02012106A (es) Polipeptidos y acidos nucleicos relacionados con b7 empleados para inmunomodulacion.
ATE366814T1 (de) Gl50 moleküle, sowie verwendungen derselben
ATE270337T1 (de) Materialen und methoden im zusammenhang mit bindung und präsentation von substanzen auf zelloberflächen
EP0737747A3 (de) Cytoplasmatische Expression von Antikörpern, Antikörperfragmenten und Antikörperfragment-Fusionsmolekülen in E. coli
EP1027437B8 (de) Verwendung des wnt-1 induzierten sekretierten polypeptids wisp-1
KR960701899A (ko) 인자 viii:c활성을 갖는 단백질 복합체 및 그의 제조
NO20020633D0 (no) Produksjon av proteiner
WO2001073028A3 (en) A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor
ATE406451T1 (de) Verankerte expression heterologer proteine
DE69634757D1 (de) Vektor zur expression von n-terminal verlängerten proteinen in hefezellen
DE59712771D1 (de) Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung
KR870007280A (ko) 바실러스에서의 사람 혈청 알부민의 제조방법
ATE354663T1 (de) Eine mycobacterium tuberculosis kodierende sequenz zur expression von heterologen proteinen
WO2000018923A3 (en) Slgp protein and nucleic acid molecule and uses therefor
AU2789000A (en) Sequences for improving the efficiency of secretion of non-secreted proteins from mammalian and insect cells
WO2002024898A3 (en) 47647, a human lipase and uses therefor
EP1241179A3 (de) Menschliches Cornichon-ähliches Protein und dafür kodierende Nukleinsäure
WO2000032746A3 (en) Netrin-like and ependymin-like nucleic acids and polypeptides and uses thereof
EP1251139A3 (de) Menschliches mindin-ähliches Protein und dafür kodierende Nukleinsäure

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties